Opportunity

DIBBS #SPE2DP-26-T-2401

DLA Solicitation for Moxifloxacin Hydrochloride Tablets, 400 mg, 30-count Bottle

Posted

March 26, 2026

Respond By

March 31, 2026

Identifier

SPE2DP-26-T-2401

NAICS

325412

This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA soliciting Moxifloxacin Hydrochloride Tablets for military medical logistics. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. - DR REDDY'S LABORATORIES, INC. - RISING PHARMA HOLDINGS, INC. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 (also referenced as 6505015034772) - Approved part numbers: NDC00093-7387-56 (Teva), NDC55111-0112-30 (Dr Reddy's), NDC57237-0156-30 (Rising Pharma) - Quantity: 1 bottle - Notable Requirements: - Delivery required within 20 days, FOB destination to Fort Bragg, NC - Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1A - Shelf life must be 36 months, non-extendable - Storage at controlled room temperature; avoid high humidity - Compliance with DFARS and FAR clauses, including cybersecurity and hazardous material handling - Delivery Location: - Fort Bragg, NC (BLD A5474 Pratt St, 28310) - Contracting Office: - DLA Troop Support Medical Supply Chain Pharmacy FSA, 700 Robbins Avenue, Philadelphia, PA

Description

MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7016046455) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing